Market Research Report

Global Teriflunomide Market Report By Type (Tablets, Powder), By Application (Immunosuppression, Cancer Treatment, Multiple sclerosis, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11212742
April 2021
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Teriflunomide Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
 
Teriflunomide is the active metabolite of leflunomide used to treat multiple sclerosis. It is an immunomodulatory drug that inhibits the synthesis of pyrimidine de novo by blocking the enzyme dihydroorotate dehydrogenase. It works by inhibits rapidly dividing cells, including activated T cells, which are thought to drive the disease process in multiple sclerosis. It is sold under the brand name Aubagio.
 
Market Dynamics
 
The rising burden of multiple sclerosis, cancer, and autoimmune disease, together with growing FDA, drives the growth of the global teriflunomide market. Teriflunomide is majorly used in the treatment of relapsing and remitting forms of multiple sclerosis. Teriflunomide is a potential candidate for multiple sclerosis treatment. In recent years, the FDA has approved the number of companies for teriflunomide. As per findings from a National MS Society study, it is estimated that nearly 1 million people in the United States live with multiple sclerosis, and 2.3 million people live with MS globally. About 200 new cases are diagnosed each week in the United States. The role of teriflunomide among the growing number of treatment options will further amplify the demand. It is promising for other diseases like cancer and autoimmune disorders. Looking into the trends, teriflunomide is projected to foresee tremendous growth in the coming years.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of teriflunomide.
 
Market Segmentation
 
The entire Teriflunomide market has been sub-categorized into type, application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type
  • Tablets
  • Powder
 
By Application
  • Immunosuppression
  • Cancer Treatment
  • Multiple sclerosis
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for teriflunomide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Teriflunomide Market Share by Region (Representative Graph)
 
Global Teriflunomide Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the teriflunomide market include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals, Msn Laboratories Private Limited, Alembic Pharmaceuticals, Natco. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Teriflunomide Market
       2.2. Global Teriflunomide Market Snapshot
 
3 . TERIFLUNOMIDE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Teriflunomide Market
       3.3. Market Restraints of Teriflunomide Market
       3.4. Opportunities of Teriflunomide Market
       3.5. Trends of Teriflunomide Market
       3.6. Porter’s Five Force Analysis of Teriflunomide Market
       3.7. Teriflunomide Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Teriflunomide Value Chain Analysis
       4.2. Teriflunomide Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Teriflunomide Raw Material Manufactures List
           4.2.3. Price Trend of Teriflunomide Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Teriflunomide Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Teriflunomide Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Teriflunomide Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Teriflunomide Market
 
6 . GLOBAL TERIFLUNOMIDE MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Teriflunomide Market Analysis by Type
       6.3 Market Analysis of Tablets by Regions
       6.4 Market Analysis of Powder by Regions
 
7 . GLOBAL TERIFLUNOMIDE MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Teriflunomide Market Analysis by Application
       7.3 Market Analysis of Immunosuppression by Regions
       7.4 Market Analysis of Cancer Treatment by Regions
       7.5 Market Analysis of Multiple sclerosis by Regions
       7.6 Market Analysis of Others by Regions
 
8 . GLOBAL TERIFLUNOMIDE MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Teriflunomide Market Estimate by Market Segment
           8.3.3. North America Teriflunomide Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Teriflunomide Market Estimate by Market Segment
           8.4.3. Europe Teriflunomide Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Teriflunomide Market Estimate by Market Segment
           8.5.3. Asia Pacific Teriflunomide Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Teriflunomide Market Estimate by Market Segment
           8.6.3. Latin America Teriflunomide Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Teriflunomide Market Estimate by Market Segment
           8.8.3. Middle East & Africa Teriflunomide Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE TERIFLUNOMIDE COMPANIES
       9.1. Teriflunomide Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF TERIFLUNOMIDE INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Sanofi Aventis
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Genzyme Corporation
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Amneal Pharmaceuticals NY LC
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Glenmark Pharmaceuticals
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Msn Laboratories Private Limited
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Alembic Pharmaceuticals
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Natco
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Global Teriflunomide Market Snapshot
  •  Drivers of The Global Teriflunomide Market Impact Analysis
  •  Restraints of The Global Teriflunomide Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Teriflunomide Market: Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Teriflunomide Market Size In 2020, By Scenario
  •  COVID-19: Micro and Macro Factor Analysis on Teriflunomide Market
  •  Global Teriflunomide Market Analysis by Type (USD MN)
  •  Global Teriflunomide Market Analysis in Tablets by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Powder by Geography (USD MN)
  •  Global Teriflunomide Market Analysis by Application (USD MN)
  •  Global Teriflunomide Market Analysis in Immunosuppression by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Cancer Treatment by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Multiple sclerosis by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Others by Geography (USD MN)
  •  Global Teriflunomide Market by Geography (USD MN)
  •  North America Teriflunomide Market Analysis by Type (USD MN)
  •  North America Teriflunomide Market Estimate by Application (USD MN)
  •  North America Teriflunomide Market Estimate by Country (USD MN)
  •  United State Teriflunomide Market Analysis by Type (USD MN)
  •  United State Teriflunomide Market Estimate by Application (USD MN)
  •  Rest of North America Teriflunomide Market Analysis by Type (USD MN)
  •  Rest of North America Teriflunomide Market Estimate by Application (USD MN)
  •  Europe Teriflunomide Market Analysis by Type (USD MN)
  •  Europe Teriflunomide Market Estimate by Application (USD MN)
  •  United Kingdom Teriflunomide Market Analysis by Type (USD MN)
  •  United Kingdom Teriflunomide Market Estimate by Application (USD MN)
  •  France Teriflunomide Market Analysis by Type (USD MN)
  •  France Teriflunomide Market Estimate by Application (USD MN)
  •  Germany Teriflunomide Market Analysis by Type (USD MN)
  •  Germany Teriflunomide Market Estimate by Application (USD MN)
  •  Rest of Europe Teriflunomide Market Analysis by Type (USD MN)
  •  Rest of Europe Teriflunomide Market Estimate by Application (USD MN)
  •  Asia Pacific Teriflunomide Market Analysis by Type (USD MN)
  •  Asia Pacific Teriflunomide Market Estimate by Application (USD MN)
  •  Asia Pacific Teriflunomide Market Estimate by Country (USD MN)
  •  China Teriflunomide Market Analysis by Type (USD MN)
  •  China Teriflunomide Market Estimate by Application (USD MN)
  •  Japan Teriflunomide Market Analysis by Type (USD MN)
  •  Japan Teriflunomide Market Estimate by Application (USD MN)
  •  India Teriflunomide Market Analysis by Type (USD MN)
  •  India Teriflunomide Market Estimate by Application (USD MN)
  •  Rest of Asia Pacific Teriflunomide Market Analysis by Type (USD MN)
  •  Rest of Asia Pacific Teriflunomide Market Estimate by Application (USD MN)
  •  Latin America Teriflunomide Market Analysis by Type (USD MN)
  •  Latin America Teriflunomide Market Estimate by Application (USD MN)
  •  Latin America Teriflunomide Market Estimate by Country (USD MN)
  •  Brazil Teriflunomide Market Analysis by Type (USD MN)
  •  Brazil Teriflunomide Market Estimate by Application (USD MN)
  •  Rest of Latin America Teriflunomide Market Analysis by Type (USD MN)
  •  Rest of Latin America Teriflunomide Market Estimate by Application (USD MN)
  •  Middle East & Africa Teriflunomide Market Analysis by Type (USD MN)
  •  Middle East & Africa Teriflunomide Market Estimate by Application (USD MN)
  •  Middle East & Africa Teriflunomide Market Estimate by Country (USD MN)
  •  Middle East Teriflunomide Market Analysis by Type (USD MN)
  •  Middle East Teriflunomide Market Estimate by Application (USD MN)
  •  Africa Teriflunomide Market Analysis by Type (USD MN)
  •  Africa Teriflunomide Market Estimate by Application (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis
 
 LIST OF FIGURES
 
  •  Research Scope of Teriflunomide Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Teriflunomide Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Teriflunomide Market Analysis by Type (USD MN)
  •  Global Teriflunomide Market Analysis in Tablets by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Powder by Geography (USD MN)
  •  Global Teriflunomide Market Analysis by Application (USD MN)
  •  Global Teriflunomide Market Analysis in Immunosuppression by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Cancer Treatment by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Multiple sclerosis by Geography (USD MN)
  •  Global Teriflunomide Market Analysis in Others by Geography (USD MN)
  •  Latin America Teriflunomide Market by Revenue
  •  Middle East & Africa Teriflunomide Market by Revenue
  •  Recent Development in Teriflunomide Industry
  •  Company Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
 

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials